Technology, Capital and Collaboration Will Drive Bio/Med in NYS
“In New York State, there is a lot to be proud of and a lot to be excited about. The breadth of companies and technologies and capability that we have in this region is truly impressive.”
Location: Pittsford, N.Y.
Description: RTEmd’s first client from 33 years ago remains their customer today. RTEmd is focused on understanding and improving their clients’ business through a disciplined approach to product development and quality/regulatory services. From frontline medical devices to information systems, automation systems and remote connectivity, RTEmd has experience with: patient monitoring medical imaging, in-vitro diagnostics, electro-medical systems, surgical applications, ophthalmology, nephrology, infusion pumps and medical imaging.
Employees: 30 New York State
Rapidly changing bioscience and medical technology (Bio/Med) is taking the industry in new directions and RTEmd represents one New York company taking advantage.
The Rochester-based tech producer creates and maintains software for medical device manufacturers. From front-line medical devices to information systems, automation systems and remote connectivity, RTEmd has experience with patient monitoring, medical imaging, in-vitro diagnostics, electro-medical systems, surgical applications, ophthalmology, nephrology and infusion pumps.
There’s a lot to look forward to in the industry right now, said Bob Ruppenthal, who founded RTEmd in 1981.
“This is an exciting time in our industry,” he said. “There’s a tremendous transformation coming in multi-dimensions. The continued advance of computerization driven by miniaturization allows us to get so much more powerful computing capability into a smaller footprint for a smaller cost.
“We have all the ubiquitous connectivity that the smartphones have brought to bear and that is impacting medical technology in a profound way; in ways that we haven’t fully begun to imagine yet,” Ruppenthal said.
While New York has a healthy stream of well-trained engineers and technicians coming out of colleges, academia could still do more to benefit Bio/Med. The industry needs to address the absence of regulatory training at the college level, said Ruppenthal.
“There’s an opportunity for our educational institutions to fill a need,” he said, commenting that virtually every Bio/Med professional should have training in the quality and regulatory space. “Our industry needs competent people with expertise in that area.”
There’s also opportunity for collaboration among Bio/Med companies across the state. Networking will be key as the industry moves forward in New York, Ruppenthal said.
“There’s an opportunity for a mentoring relationship between the large company and the emerging company to get it ready for prime time,” he said. “When we think about how we can stimulate the growth of the industry within the region, it’s creating the opportunities to bring those entities together for those kinds of commercial collaborations.
“In New York State, there is a lot to be proud of and a lot to be excited about,” Ruppenthal said. “The breadth of companies and technologies and capability that we have in this region is truly impressive. And we’ve certainly got an opportunity to accelerate that.”